Skip to content

Clinical research on reguulating nasal ability in patients with seasonal allergic rhinitis treat by preventive puncturing sphenopalatine ganglion

Clinical research on reguulating nasal ability in patients with seasonal allergic rhinitis treat by preventive puncturing sphenopalatine ganglion

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005608
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Needle acupuncture intervention before rhinitis attack:Needle prick intervention after rhinitis attack
Study Group:Needle acupuncture intervention before rhinitis attack

Sponsors

Department of Acupuncture-Moxibustion,Beijing Tongren Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) At least two years in the same season break out, pollen transmission at the same time.2)The symptoms were in accordance with nasal itching, sneezing, nasal secretions and nasal congestion. 3) Nasal mucosa pale, edema or hyperemia, swelling nasal mirror, with or without conjunctival congestion, edema and swellin. 4)Age between 18 to 65 years old. 5) Voluntarily sign informed consent. 6)Accord with the diagnosis of seasonal allergic rhinitis.7) No other antiallergic treatment was received at least one week before entering the group.

Exclusion criteria

Exclusion criteria: 1) Patients with abnormal body temperature; 2) Patients with history of halo acupuncture; 3) Structural deformity of nasal cavity; 4) Abnormal anatomical structure around acupuncture pathway; 5) Patients with local infection or other acupuncture may induce intracranial infection; 6) Taking rhinitis related drugs for a long time; 7) Patients with abnormal cardiovascular and cerebrovascular, liver, kidney and coagulation functions; 8) Psychotic patients.

Design outcomes

Primary

MeasureTime frame
Nasal airway resistance;total nasal symptom score, TNSS;total non-nasal symptom score, TNNSS;Nasal acoustic reflex;

Secondary

MeasureTime frame
rhinoconjunctivitis quality of life questionnaire, RQLQ;

Countries

China

Contacts

Public ContactLu-quan Chen
chenluquan@hotmail.com50268094

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026